"The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume", the company said on Saturday.
AstraZeneca should still know by year-end whether its experimental vaccine protects people against coronavirus, as long as it is cleared to resume trials soon, its chief executive said on Thursday amid doubts over its rollout.
AstraZeneca Plc and Oxford pause major vaccine trial for second time.
UK drugmaker and Oxford Biomedica to produce more of potential coronavirus product
The price set by the US pharmaceutical company is above the $ 19.50 (16.5 euros) that he advanced Pfizer for the vaccine that develops together with the German BioNTech and which is, as in the case of Moderna, at the beginning of phase 3. It is also immensely higher than the cost it has set AstraZeneca, which collaborates with the Oxford University, for Germany, Italy, France and the Netherlands: between 3 and 4 dollars (2.5 and 3.4 euros) per dose.
